Literature DB >> 6178361

PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables.

R Salonen, J Ilonen, M Reunanen, J Nikoskelainen, A Salmi.   

Abstract

Interferon production after stimulation of lymphocytes with purified protein derivative, pokeweed mitogen, and phytohemagglutinin was studied in 39 patients with stable multiple sclerosis (MS) and 39 age- and sex-matched controls. Stable MS patients produced less interferon, and the number of subjects producing undetectable amounts of interferon was higher in the MS group (11/39) than in the control group (2/39). A tendency toward an association between low interferon production and HLA-Dw2 antigen was found in MS patients. There was no clear-cut correlation between interferon production and the duration of disease or disability of the patients. Although there was no systematic correlation of age with interferon production, patients older than 55 years tended to be very poor interferon producers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178361     DOI: 10.1002/ana.410110308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

2.  Toxic effects of interferon administered intrathecally.

Authors:  J Ruutiainen; M Panelius; K Cantell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

Review 3.  Multiple sclerosis. Current concepts in management.

Authors:  B Giesser
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

4.  Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.

Authors:  G Vervliet; H Deckmyn; H Carton; A Billiau
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

5.  In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.

Authors:  G Vervliet; L Schandené
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.

Authors:  G Vervliet; H Carton; A Billiau
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Interferon production by cultured peripheral leucocytes of MS patients.

Authors:  G Vervliet; H Carton; E Meulepas; A Billiau
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis.

Authors:  K P Wandinger; K Wessel; P Neustock; A Siekhaus; H Kirchner
Journal:  J Neurol Sci       Date:  1997-07       Impact factor: 3.181

Review 9.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.